Robert A. Bradway - May 2, 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Chairman, CEO and President, Director
Signature
/s/ Andrea A. Robinson, Attorney-in-Fact for Mr. Bradway
Stock symbol
AMGN
Transactions as of
May 2, 2023
Transactions value $
-$675,582
Form type
4
Date filed
5/4/2023, 08:23 PM
Previous filing
May 2, 2023
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Award $0 +13.5K +2.13% $0.00 647K May 2, 2023 Direct F1
transaction AMGN Common Stock Tax liability -$676K -2.86K -0.44% $235.97 644K May 3, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMGN Nqso (Right to Buy) Award $0 +114K $0.00 114K May 2, 2023 Common Stock 114K $235.97 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.
F2 These shares include the following RSUs granted under the Company's equity plans: 8,164 RSUs which will vest in installments of 4,021 on 5/5/2023 and 4,143 on 5/5/2024; 8.898 RSUs which will vest in installments of 4,382 on 4/30/2024 and 4,516 on 4/30/2025; 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026; and 13,486 RSUs which will vest in two installments of 4,450 on 5/2/2025 and 5/2/2026, and 4,586 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3 These shares include 1,818 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4 These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.